Optimising the conditioning regimen for acute myeloid leukaemia

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Allogeneic transplantation for acute myeloid leukaemia (AML) requires potent conditioning regimens to ensure graft success and exert anti-leukaemic effects.
• Various conditioning strategies exist, including high-dose or reduced-intensity regimens with agents like total body irradiation (TBI), cyclophosphamide, fludarabine, busulfan, and anti-thymocyte globulin.
• Research over the last two decades has refined the application of these conditioning regimens.

Purpose of the Study:

• To review the evolution and impact of conditioning regimens in allogeneic stem cell transplantation for AML.
• To highlight emerging research on novel conditioning strategies aimed at improving efficacy and reducing toxicity.

Main Methods:

• Review of existing literature on conditioning regimens for AML transplantation.
• Analysis of research trends over the past two decades.
• Exploration of novel therapeutic targets and approaches, such as antibody-targeted radiotherapy.

Main Results:

• Conditioning regimens are critical for both engraftment and anti-leukaemic activity in AML transplantation.
• Established regimens involve a combination of cytotoxic agents and/or irradiation.
• Emerging research suggests that targeted radiotherapy, specifically using an anti-CD45 antibody, holds promise for enhanced tumour cell kill and reduced treatment toxicity.

Conclusions:

• Conditioning regimens are a cornerstone of allogeneic transplantation for AML, necessitating careful selection and optimization.
• Advances in research are leading to more targeted and potentially less toxic conditioning strategies.
• Targeted radiotherapy with anti-CD45 antibodies represents a promising future direction for improving outcomes in AML treatment.